{
    "SPADE_N_14511": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14511",
            "Peptide Name": "NP-1 2c analog (Synthetic AMPs, Arg-rich,  2S=S, UCBB1a)",
            "Source": "circularization, amino acid SUBSTITUTION, defensin analog, animal-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "VVGAGRRALCLPRERRAGFGRIRGRIHPLCGRR",
            "Sequence Length": 33,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antifungal"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3713.41,
            "PI": 12.0,
            "Hydrophobicity": -0.46,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Yu Q, Lehrer RI, Tam JP.2000",
                    "Reference": "J Biol Chem. 2000 Feb 11;275(6):3943-9. doi: 10.1074/jbc.275.6.3943.PubMed",
                    "Title": "Engineered salt-insensitive alpha-defensins with end-to-end circularized structures"
                }
            ],
            "Frequent Amino Acids": "RGA",
            "Absent Amino Acids": "DKMNOQSTUWY",
            "Basic Residues": 11,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 13,
            "Polar Residues": 18,
            "Positive Residues": 11,
            "Negative Residues": 1,
            "Net Charge": 10,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (87.88%) toRabbit neutrophil peptide 1 NP-1R: 30%; G: 18%.Activity: low salt, active against E. coli (MIC 1.6 ug/ml), S. typhimurium (MIC 2.5 ug/ml), P. aeruginosa (MIC 2.3 ug/ml), K. pneumoniae (MIC 5.8 ug/ml), L. monocytogenes (MIC 1.9 ug/ml), and C. albicans (MIC 21.7 ug/ml).Antimicrobial robustness: NaCl-insensitive:E. coli (100 mM), NaCl-sensitive:S. typhimurium (100 mM), NaCl-insensitive:P. aeruginosa (100 mM), NaCl-sensitive:K. pneumoniae (100 mM), NaCl-insensitive:L. monocytogenes (100 mM), NaCl-sensitive:C. albicans (100 mM).In vitro toxicity: human RBC, not hemo.lytic (HC50 4791 ug/ml).SAR: circular NP-1 peptides appeared to be less toxic.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_11034",
                    "Similarity": 1.0,
                    "Sequence": "CGRRAGGSC"
                },
                {
                    "SPADE_ID": "SPADE_N_14512",
                    "Similarity": 0.9696969696969697,
                    "Sequence": "VVGAGRRALCLPRERRAGFGRIRGRIHPLGGRR"
                },
                {
                    "SPADE_ID": "SPADE_N_14509",
                    "Similarity": 0.9393939393939394,
                    "Sequence": "VVGACRRALCLPRERRAGFCRIRGRIHPLCGRR"
                }
            ]
        }
    }
}